Revelation Partners Expands Team with Hire of Andrew Olson, Partner, Chief Financial Officer & Chief Operating Officer
Revelation Partners, a healthcare investment firm with over $1.5 billion of capital under management, announced today the addition of Andrew Olson as Partner, Chief Financial Officer and Chief Operating Officer. Mr. Olson has an extensive background in the venture capital and funds management industry. His addition to the team will enhance the firm’s technical expertise, support the differentiated investment […]
Announcing Fund IV
During the fourth quarter, we announced the final closing of our fourth flagship fund, raising $608 million. This fundraise marks a major milestone in our mission to be the premier liquidity and capital provider to the healthcare industry. Through this fundraise, we have increased our total committed capital base to over $1.5b, yet our core […]
Revelation Partners Closes $608 Million Fund, Surpassing $500 Million Target
Revelation Partners today announced the closing of its $608 million Fund IV, far surpassing the healthcare investment firm’s initial target of $500 million. Revelation Partners now manages $1.5 billion of committed capital as the firm provides liquidity and flexible capital solutions to investors, companies, limited partners and general partners across all healthcare sub-sectors.
Trane Technologies to Acquire Connected Workplace and Enterprise Asset Management Leader Nuvolo
Trane Technologies (NYSE: TT), a global climate innovator, announced that it has signed a definitive agreement to acquire Nuvolo, a global leader in modern, cloud-based connected workplace and enterprise asset management products and solutions.
How a Secondary Strategy Can Help GPs Raise Capital
Want to raise capital for your healthcare startup? Go to Sprout, Three Arch, Healthcare Ventures, Morgenthaler, Interwest, Forward, Psilos… right? Well unfortunately, these firms do not exist anymore. A decade long J curve and a Great Recession eliminated them. Despite a string of vintage year strikeouts in the mid-2000s, the allure of “disrupting” healthcare with […]
US Fertility and Ovation Come Together to Form a Platform for Growth and Expansion
US Fertility, the nation’s largest partnership of physician-owned fertility practices, and Ovation Fertility (“Ovation”), announced today that they have entered into a definitive agreement to combine and become the leading fertility company in the United States. The combined company’s enhanced platform will be well positioned to drive growth and innovation, while leveraging best practices to […]
RMA of New York Joins US Fertility
US Fertility, the largest partnership of physician-owned fertility practices in the United States, announced today that Reproductive Medicine Associates of New York (“RMA NY”) has joined its network of premier reproductive medicine practices and embryology laboratories. Together, the combined company is well-positioned to improve and expand access to world-class reproductive clinical care in the greater […]
Is Private Healthcare Still An Interesting Asset Class?
In the current interest-rate environment, many investors have been re-thinking their asset allocation strategies in order to meet or maximize their annual return targets. With many potential asset classes and sectors vying for investors’ allocation, we continue to believe that private healthcare investing is a conservative strategy during market volatility, with a potential for outsized […]
VitalConnect Secures over $30 Million in Oversubscribed Series F Financing
VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced closing on an oversubscribed Series F financing in excess of $30 million. The financing round was led by Revelation Partners with significant participation from the company’s existing investors, including Pacific General Ventures and EW Healthcare Partners.
Thoma Bravo Announces Strategic Growth Investment in Bluesight to Support the Company’s Acquisition of Medacist
Thoma Bravo, a leading software investment firm, today announced the closing of a strategic growth investment in Bluesight, the Medication Intelligence™ Company. The investment is expected to further enhance Bluesight’s drug diversion prevention offerings through its acquisition of Medacist, a pioneer in drug diversion monitoring, and continue to grow Bluesight’s inventory management and spend optimization offerings.